A Study of BEBT-209 in Combination With Chemotherapy for the Treatment of Advanced Triple-Negative Breast Cancer

NCT06685796 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Triple-Negative Breast Cancer

Interventions

DRUG: BEBT-209 capsules
DRUG: Carboplatin injection
DRUG: Gemcitabine hydrochloride for injection

Sponsor

BeBetter Med Inc